483
Shandong Anshun Pharmaceutical Co., Ltd.Shandong Anshun Pharmaceutical Co., Ltd. – FDA 483, Nov 16, 2020
Record Details
An FDA inspection of Shandong Anshun Pharmaceutical Co., Ltd., an API manufacturer in China, revealed significant issues with their quality control systems. The firm failed to follow its written stability program, resulting in stability tests not being performed by their planned due dates. Additionally, analysts in the QC Laboratory were found to be inadequately trained on analytical methods, leading to out-of-specification results due to analyst error.
View Company Profile
ID · fe9359f5-0288-407b-861c-6f57da18fbe8
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.